Ultragenyx Pharmaceutical... (RARE)
undefined
undefined%
At close: undefined
42.66
0.09%
After-hours Jan 06, 2025, 04:00 PM EST

Ultragenyx Pharmaceutical Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
Product Revenue 77.25M 73.81M 62.49M 138.06M 42.35M
Product Revenue Growth +4.67% +18.11% -54.74% +226.01% n/a
Royalty Revenue 62.24M 73.22M 46.34M 126.95M 55.70M
Royalty Revenue Growth -14.99% +57.99% -63.49% +127.90% n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018
Europe Revenue 47.53M 36.37M 26.66M 21.32M 12.09M 5.29M
Europe Revenue Growth +30.70% +36.42% +25.06% +76.40% +128.32% n/a
Japan Revenue 2.22M 1.16M 301.11M 237.67M n/a n/a
Japan Revenue Growth +91.56% -99.61% +26.69% n/a n/a n/a
Latin America Revenue 77.34M 44.71M n/a n/a n/a n/a
Latin America Revenue Growth +72.98% n/a n/a n/a n/a n/a
North America Revenue 307.15M 281.09M n/a n/a n/a n/a
North America Revenue Growth +9.27% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 80.35M 80.60M 78.16M 76.83M 74.92M 81.40M 76.65M 72.85M 69.84M 68.14M 67.31M 59.43M 53.88M 53.41M 53.26M 51.04M 42.12M 42.25M 47.52M 41.88M 41.01M 39.81M 38.83M 34.48M 31.09M 30.72M 31.43M 37.72M 23.50M 20.00M 18.68M 19.81M 17.18M 14.74M 13.21M 11.59M 10.23M 7.04M 4.14M
Selling, General, and Administrative Revenue Growth -0.31% +3.13% +1.73% +2.56% -7.97% +6.21% +5.21% +4.31% +2.50% +1.23% +13.26% +10.30% +0.89% +0.29% +4.34% +21.17% -0.31% -11.08% +13.47% +2.12% +3.00% +2.53% +12.63% +10.87% +1.23% -2.28% -16.66% +60.52% +17.47% +7.06% -5.67% +15.28% +16.59% +11.59% +13.92% +13.30% +45.38% +70.08% n/a
Research and Development Revenue 170.11M 152.64M 169.64M 160.56M 157.25M 164.95M 165.70M 170.81M 237.30M 154.53M 143.16M 123.01M 113.42M 113.20M 147.52M 131.10M 87.31M 80.71M 112.96M 83.06M 100.14M 96.05M 78.11M 71.62M 70.04M 76.83M 75.50M 61.53M 60.41M 58.44M 51.27M 50.75M 48.71M 43.33M 40.41M 44.56M 29.70M 23.10M 17.36M
Research and Development Revenue Growth +11.44% -10.02% +5.66% +2.11% -4.67% -0.45% -2.99% -28.02% +53.56% +7.95% +16.37% +8.46% +0.19% -23.26% +12.52% +50.15% +8.18% -28.55% +36.00% -17.06% +4.27% +22.97% +9.06% +2.25% -8.84% +1.76% +22.72% +1.85% +3.38% +13.98% +1.03% +4.18% +12.41% +7.22% -9.31% +50.03% +28.57% +33.06% n/a

Create Price Alert on RARE

Your price alert will notify you when the stock price is above 42.62.

Add to Watchlist